8012-3246 is a selective PLK2 inhibitor with an IC50 of 774.5 nM. 8012-3246 suppresses GSK3β phosphorylation. 8012-3246 exhibits potent anticancer activity against colorectal cancer [1].
References:
[1]. Wu YW, et al. Consensus Pharmacological Interactions for PLK2 Inhibitor Identification in Colorectal Cancer Treatment. J Chem Inf Model. 2026 Jan 12;66(1):577-590.
References:
[1]. Wu YW, et al. Consensus Pharmacological Interactions for PLK2 Inhibitor Identification in Colorectal Cancer Treatment. J Chem Inf Model. 2026 Jan 12;66(1):577-590.
















